Filing Flows › DocGo (DCGO) › R&D spending
DocGo (DCGO) R&D spending by quarter
DocGo's R&D spending was $3.4M in Q2 2026 (second quarter 2026), -7% from Q1 2026. Over the last 7 quarters it ranged from $3.0M (Q2 2025) to $3.8M (Q4 2025).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $3.4M | -7% | +17% |
| Q1 2026 | $3.7M | -2% | +2% |
| Q4 2025 | $3.8M | +18% | +2% |
| Q3 2025 | $3.2M | +8% | — |
| Q2 2025 | $3.0M | -19% | — |
| Q1 2025 | $3.6M | -1% | — |
| Q4 2024 | $3.7M | — | — |
Q2 2026 at a glance
DocGo, Q2 2026: revenue $73.4M (-9% year over year), operating margin -24.4%, net loss $18.0M, operating cash flow −$9.2M. The chart follows the revenue to costs, profit and cash.
Questions
What is DocGo's R&D spending?
DocGo's R&D spending was $3.4M in Q2 2026 (second quarter 2026), -7% from Q1 2026.
How has DocGo's R&D spending changed?
Over the last 7 quarters it ranged from $3.0M (Q2 2025) to $3.8M (Q4 2025).